A study from Pfizer’s latest clinical trial showed an efficacy of 100% in more than 2,000 children between the ages of 12 and 15 at the end of March.
A study from Pfizer’s latest clinical trial showed an efficacy of 100% in more than 2,000 children between the ages of 12 and 15 at the end of March.
The fight against the pandemic is including the youngest yet with the Food and Drug Administration clearing the way for children..